Abstract
The activities of catalase, glutathione peroxidase, and glutathione reductase, were not significantly different from normal whereas that of superoxide dismutase was decreased (P<0.05) in erythrocytes from patients with multiple sclerosis. Assay of the lipid peroxidation product, malondialdehyde, after incubation of erythrocytes with 10 mM H2O2 under carefully controlled conditions (peroxide stress test) demonstrated that MS erythrocytes are significantly (P<0.001) less susceptible to H2O2-induced lipid peroxidation in vitro. This finding suggests that the level of an endogenous antioxidant, possibly vitamin E, may be elevated in MS red cells. After treatment with hyperbaric O2, the activity of MS erythrocyte catalase is significantly (P<0.01) elevated by 2–6-fold.
Similar content being viewed by others
References
Davison, A. N. 1978. Progress in recent research on multiple sclerosis. Biochem. Soc. Trans. 6:443–447.
McFarlin, D. E., andMcFarland, H. F. 1982. Medical progress: multiple sclerosis. New Eng. J. Med. 307:1246–1251.
Kurantsin-Mills, J., Samji, N., Moscarello, M. A., andBoggs, J. M. 1982. Comparison of membrane structure, osmotic fragility and morphology of multiple sclerosis and normal erythrocytes. Neurochem. Res. 7:1523–1540.
Berner, B., Blanco, C. E., Ellison, G. W., Myers, L. W., andHirsch, H. E. 1980. Partition coefficients of 2,2,6,6-tetramethylpiperidine-1-oxyl in erythrocyte lipids in multiple sclerosis. J. Neurosci. Res. 5:225–232.
Prineas, J. 1968. Red blood cell size in multiple sclerosis. Acta Neurol. Scand. 44:81–90.
Plum, C. M., andFog, T. 1959. Studies in multiple sclerosis. Acta Psych. Neurol. Scand. (suppl. 128) 34:13–14.
Caspary, E. A., Sewell, F., andField, E. J. 1967. Red blood cell fragility in multiple sclerosis. Brit. Med. J. 2:610–611.
Stasiw, D. M., Rosato, S., Mazza, J., andCerny, L. C. 1977. Quantitative osmotic fragility and disease states: a preliminary study. J. Lab. Clin. Med. 89:409–413.
Schauf, C. L., Frischer, H., andDavis, F. A. 1980. Mechanical fragility of erythrocytes in multiple sclerosis. Neurology 30:323–325.
Field, E. J., Joyce, G., andSmith, B. M. 1977. Erythrocyte-UFA (EUFA) mobility test for multiple sclerosis: Implications for pathogenesis and handling of the disease. J. Neurol. 214:113–127.
Field, E. J., andJoyce, G. 1976. Simplified laboratory test for multiple sclerosis. Lancet ii Aug 14:367–368.
Tappel, A. L. 1978. Protection against free radical lipid peroxidation reactions. Adv. Exp. Med. Biol. 97:111–131.
McCay, P. B. 1981. Physiological significance of lipid peroxidation Fed. Proc. 40:173.
Hunter, M. I. S., Brzeski, M. S., andde Vane, P. J. 1981. Superoxide dismutase, glutathione peroxidase and thiobarbituric acid-reactive compounds in erythrocytes in Duchenne muscular dystrophy. Clin. Chim. Acta 115:93–98.
Halliwell, B. 1982. Superoxide and superoxide-dependent formation of hydroxyl radicals are important in oxygen toxicity. Trends Biochem. Sci. 7:270–272.
Swank, R. L. 195 Multiple sclerosis: A correlation of its incidence with dietary fat. Am. J. Med. Sci. 220:421–430.
Sinclair, H. M. 1956. Deficiency of essential fatty acids and atherosclerosis etc. Lancet i:381–383.
Mertin, J., andMeade, C. J. 1977. Relevance of fatty acids in multiple sclerosis. Brit. Med. Bull. 33:67–71.
Yu, R. K., Ueno, K., Glaser, G. H., andTourtellotte, W. W. 1982. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39:464–477.
Woelk, H., andBorri, P. 1973. Lipid and fatty acid composition of myelin purified from normal and MS brains. Eur. Neurol. 10:250–260.
Gopfert, E., Pytlik, S., andDebuch, H. 1980. 2′. 3′-Cyclic nucleotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J. Neurochem. 34:732–739.
Kobayashi, T., Mawatari, S., andKuroiwa, Y. 1978. Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy. Clin. Chim. Acta 85:259–266.
Mickel, H. S. 1975. Multiple sclerosis: a new hypothesis. Perspect. Biol. Med. 18:363–374.
Wickstrom, J., Westermarck, T., andPalo, J. 1976. Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol. Scand. 54:287–290.
Thompson, R. H. S. 1975. Unsaturated fatty acids in multiple sclerosis. Pages 184–191,in Davison, A. N., Humphrey, J. H., Liversedge, L. A., McDonald, W. I., andPorterfield, J. S. (eds.). Multiple sclerosis research. HMSO: London.
Rogovina, N. I. andKoklov, A. P. 1980. Metabolism of lipid peroxidation products in multiple sclerosis patients. Zh. Nevropatol. Paikhiatr. Im. S. S. Korsakova 80:696–700.
Shukla, V. K. S., Jensen, G. E. &Clausen, J. 1977. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 56:542–550.
Szeinberg, A., Golan, R., Ezzer, J. B., Sarova-Pinhas, I., Sadeh, M. andBraham, J. 1978. Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta. Neurol. Scand. 60:265–271.
Szeinberg, A., Golan, R., Ben-Ezzer, J., Sarova-Pinhas, I., andKindler, D. 1981. Glutathione peroxidase activity in various types of blood cell in multiple sclerosis. Acta Neurol. Scand. 63:67–75.
Jensen, G. E., Gissel-Neilsen, G., andClausen, J. 1980. Leukocyte glutathione peroxidase E.C. 1.11.1.9 activity and selenium level in multiple sclerosis. J. Neurol. Sci. 48:61–68.
James, P. B. 1982. Evidence for subacute fat embolism as the cause of multiple sclerosis. Lancet i Feb 13:380–386.
Fischer, B. H., Marks, M., andReich, T. 1983. Hyperbaric oxygen treatment of multiple sclerosis: a randomized, placebo controlled double blind study. N. Engl. J. Med 308:181–186.
Fridovich, I. 1979. Superoxide dismutases: defence against endogenous superoxide radical. Pages 81–82.in: Oxygen free radicals and tissue damage. CIBA Foundation Symp. 65:
Hunter, M. I. S., andAmin, K. 1983. Red cell catalase and glutathione reductase in Duchenne muscular dystrophy. IRCS Med. Sci. 11:341–342.
Stocks, J., andDormandy, T. L. 1971. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br. J. Haematol. 20:95–111.
Hopkins, J., andTudhope, G. R. 1973. Glutathione peroxidase in health and disease. Brit. J. Haematol. 25:563–575.
Beutler, E., Blume, K. G., Kaplan, J. C., Lohr, G. W., Ramot, B., andValentine, W. N. 1977. International committee for standardization in haemotology: recommended methods for red cell enzyme analysis. Brit. J. Haematol. 35:331–340.
Das, S. K., andNair, R. C. 1980. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Brit. J. Haemotol. 44:87–92.
Mehlert, A., Metcalfe, A., Diplock, A. T., andHughes, R. A. C. (1982) Glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 65:376–378.
Clements, J. E., andAnderson, B. B. 1980. Glutathione reductase activity and pyridoxine (pyridoxamine) phosphate oxidase activity in the red cell. Biochim. Biophys. Acta 632:159–163.
Beutler, E. 1974. Glutathione reductase Pages, 109–112;in:Flohe, L. et al., (eds.) Proc. 16th Conf. German Soc. Biol. Chem. Thieme: Stuttgart.
Sinet, P.-M., Lejeune, J., andJerome, H. 1979. Trisomy 21 (Down's syndrome) gluthathione peroxidase, hexose monophosphate shunt and I. Q. Life Sci. 24:29–34.
Crapo, J. D., andMcCord, J. M. 1976. Oxygen-induced changes in pulmonary superoxide dismutase assayed by antibody titrations. Am. J. Physiol. 231:1196–1203.
Vanella, A., Pinturo, R., Grimaldi, R., Tiriolo, P., Di Silvestro, I., Grasso, M., D'Urso, G., andGeremia, E. 1981. Superoxide dismutase activities in rat brain: effect of hyperoxia. IRCS Med. Sci. 9:144–145.
Somayajulu, R. S. N., Mukherjee, S. P., Lynn, W. S., andBennett, P. B. 1978. Pulmonary oxygen toxicity in chickens and rabbits. Undersea Biomed. Res. 5:1–8.
Noda, Y., McGeer, P. L., andMcGeer, E. G. 1983. Lipid peroxide distribution in brain and the effect of hyperbaric oxygen. J. Neurochem. 40:1329–1332.
Hilton, J. G., Brown, G. L., andProctor, P. H. 1980. Nervous system toxicity of hyperbaric oxygen. Toxicol. Appl. Pharmacol. 53:50–53.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, M.I.S., Lao, M.S., Burtles, S.S. et al. Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen. Neurochem Res 9, 507–516 (1984). https://doi.org/10.1007/BF00964377
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964377